These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6141606)

  • 1. A pharmacokinetic/pharmacodynamic/receptor binding model to predict the onset and duration of pharmacological activity of the benzodiazepines.
    Jack ML; Colburn WA; Spirt NM; Bautz G; Zanko M; Horst WD; O'Brien RA
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):629-35. PubMed ID: 6141606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to the pharmacokinetics and pharmacodynamics of benzodiazepines.
    McKenzie SG
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):623-7. PubMed ID: 6141605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical pharmacokinetics of midazolam, flunitrazepam and diazepam (author's transl)].
    Lauven PM; Stoeckel H; Schwilden H; Schüttler J
    Anasth Intensivther Notfallmed; 1981 Jun; 16(3):135-42. PubMed ID: 6114680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of diazepam, midazolam, and lorazepam in cigarette smokers.
    Ochs HR; Greenblatt DJ; Knüchel M
    Chest; 1985 Feb; 87(2):223-6. PubMed ID: 3155675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midazolam and other benzodiazepines.
    Olkkola KT; Ahonen J
    Handb Exp Pharmacol; 2008; (182):335-60. PubMed ID: 18175099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radioreceptor assay to study the affinity of benzodiazepines and their receptor binding activity in human plasma including their active metabolites.
    Dorow RG; Seidler J; Schneider HH
    Br J Clin Pharmacol; 1982 Apr; 13(4):561-5. PubMed ID: 6121579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between EEG dynamics and pharmacokinetics of the benzodiazepine lormetazepam.
    Kurowski M; Ott H; Herrmann WM
    Pharmacopsychiatria; 1982 May; 15(3):77-83. PubMed ID: 6124982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacology of midazolam.
    Pieri L
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):17S-27S. PubMed ID: 6138073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam.
    Ellinwood EH; Heatherly DG; Nikaido AM; Bjornsson TD; Kilts C
    Psychopharmacology (Berl); 1985; 86(4):392-9. PubMed ID: 2863843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine hypnotics: time course and potency of benzodiazepine receptor occupation after oral application.
    Müller WE; Stillbauer AE
    Pharmacol Biochem Behav; 1983 Apr; 18(4):545-9. PubMed ID: 6135228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepines: relationship between pharmacological activity in the rat and in vivo receptor binding.
    Mennini T; Cotecchia S; Caccia S; Garattini S
    Pharmacol Biochem Behav; 1982 Apr; 16(4):529-32. PubMed ID: 6122216
    [No Abstract]   [Full Text] [Related]  

  • 12. Diazepam versus lorazepam: relationship of drug distribution to duration of clinical action.
    Greenblatt DJ; Divoll M
    Adv Neurol; 1983; 34():487-91. PubMed ID: 6131586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazepam: prediction of pharmacodynamics from pharmacokinetics.
    Ellinwood EH; Nikaido A; Heatherly D
    Psychopharmacology (Berl); 1984; 83(3):297-8. PubMed ID: 6089249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between plasma levels and psychological effects of benzodiazepines.
    Ziegler G; Ludwig L; Klotz U
    Pharmacopsychiatria; 1983 May; 16(3):71-6. PubMed ID: 6136997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benzodiazepine receptor ligand CL218,872 has both anxiolytic and sedative properties in rodents.
    Oakley NR; Jones BJ; Straughan DW
    Neuropharmacology; 1984 Jul; 23(7A):797-802. PubMed ID: 6147788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and receptor binding changes during chronic lorazepam administration.
    Fahey JM; Pritchard GA; Grassi JM; Pratt JS; Shader RI; Greenblatt DJ
    Pharmacol Biochem Behav; 2001; 69(1-2):1-8. PubMed ID: 11420062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midazolam as an intravenous induction agent in the elderly: a clinical and pharmacokinetic study.
    Kanto J; Aaltonen L; Himberg JJ; Hovi-Viander M
    Anesth Analg; 1986 Jan; 65(1):15-20. PubMed ID: 2934006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the activity and fate of benzodiazepines in the body.
    van der Kleijn E; Vree TB; Baars AM; Wijsman R; Edmunds LC; Knop HJ
    Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):85S-98S. PubMed ID: 6133540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quinolines PK 8165 and PK 9084 possess benzodiazepine-like activity in vitro but not in vivo.
    Keane PE; Simiand J; Morre M
    Neurosci Lett; 1984 Mar; 45(1):89-93. PubMed ID: 6145125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepine receptors': correlation with pharmacological responses in living animals.
    Mennini T; Garattini S
    Life Sci; 1982 Nov; 31(19):2025-35. PubMed ID: 6129557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.